AstraZeneca scraps plan to expand vaccine plant in the UK

AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in ...
The government may have strong arguments for denying AstraZeneca's demands, but they may be harder to sustain given the sector - high-growth life sciences; the company - Britain's largest by market ...
Telegraph investigation has found ‘critical’ information was missing from early warnings about vaccine’s side effects ...
AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state funding ...
The move comes as the company faces ‘several challenges’ around the launching of medicines and timed out patents ...
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...